People’s Vaccine Alliance, a coalition of organisations like Amnesty International, Oxfam and Global Justice Now, has claimed that rich countries are hoarding doses of COVID-19 vaccines. The body further claims that as many as 70 lower-income countries will be able to vaccinate only one in 10 people.

On a related note, Covax also has access to 700 million doses that will be equally distributed among 92 lower-income countries that have signed up. Meanwhile, Oxford-AstraZeneca has pledged to give its 64% of its doses to the developing nations.

Despite this, People’s Vaccine Alliance emphasises that there is not enough for everyone. As per their analysis, rich countries have stocked up plenty of doses to vaccinate their entire populations over three times. It claims that Canada has ordered vaccines which is sufficient to protect Canadian five times.

Data says that eight main vaccine candidates in Phase 3 trials have deals with rich countries. Though wealthy nations merely represent 14% of the world’s population, they have purchased 53% of the substantial and promising vaccines.

“No-one should be blocked from getting a life-saving vaccine because of the country they live in or the amount of money in their pocket. But unless something changes dramatically, billions of people around the world will not receive a safe and effective vaccine for Covid-19 for years to come,” said Anna Marriott, Oxfam’s health policy manager.

Hence, the People’s Vaccine Alliance wants pharmaceutical corporations to share their COVID-19 vaccine technology and intellectual property so that doses are made available across the world.